| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e8c24d4c8dc7c715f3a6cd7a024af30 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0590a4612879c777ef33aec80b098482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c7f13c04fe3efb17ce7d2d3df3df12d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73bcb85837edfc9a50844b966da7734e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8940a292c65466e8d33c4880fb19eaed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_619f207ed113115e579d01e63922bb77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4173cebefd378be397807a31db2007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57461d07c5afbf53b5f4c6ef5d403c34 |
| publicationDate |
2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3107361-A1 |
| titleOfInvention |
Crystal form of lanosterol prodrug compound and application thereof |
| abstract |
The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease. |
| priorityDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |